Cubist Pharmaceuticals (United States)
Cubist Pharmaceuticals, Inc. was an American biopharmaceutical company that targeted pathogens like MRSA. . The company employed 638 people, mostly in Lexington, Massachusetts. On 8 December 2014, Merck & Co. acquired Cubist for $102 per share in cash. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Cubist Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
38%
Total
Publications
576
Total Open
Publications
220
Total
Citations
38K
Open Access
Percentage
38%
Total
Publications
576
Total Open
Publications
220
Total
Citations
38K
Breakdown
Publisher Open
17%
Both
13%
Other Platform Open
9%
Closed
61%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 30%
53
Hybrid 10%
17
No Guarantees 60%
105
Other Platform Open
Domain 51%
66
Other Internet 45%
58
Institution 14%
18
Public 2%
3
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 66 |
DOI | Other Internet | 57 |
University of Michigan - Deep Blue | Institution | 4 |
University of Melbourne - Minerva Access | Institution | 4 |
Figshare | Public | 3 |
University of Waterloo - UWSpace | Institution | 2 |
Europe PMC | Domain | 2 |
Washington University School of Medicine - Digital Commons@Becker | Institution | 1 |
Unknown Repository | Other Internet | 1 |
UniversitĂ Cattolica del Sacro Cuore - PubliCatt | Institution | 1 |